Amkay Products Ltd
Fundamental Score
Amkay Products Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMKAY across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (16.88%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 11.44 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Strong Revenue Growth (28.98%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Strong Profit Growth Track Record (39.33% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.07)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (12.23x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (73.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Weak Earnings Growth (-55.84% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Negative Free Cash Flow (₹-7.28 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Amkay Products Ltd
About AMKAY
Business Overview
Amkay Products Limited manufactures, assembles, and markets a portfolio of medical devices, disposables, and other healthcare products in India. The company offers face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, blood pressure monitors, air bed, adult diapers, hot water bags, HIV kits, bio bags, suction machines, apron gowns, gluco strips, thermometer, vaporizer, ambu bag, fetal dropper, gel pad, body massager, breast pump, stature meter, bed bath towel, show cover, bed sheet, gloves, lancing pen, prep razor/skin blade, cord clamp, and torniquet, as well as urine pad and bag. It serves medical professionals, retailers, hospitals, prestigious institutes, government bodies, pharmaceutical companies, distributors, and dealers. The company also exports its products to Bhutan, Nepal, and internationally. Amkay Products Limited was incorporated in 2007 and is headquartered in Palghar, India.
Company Details
Key Leadership
Latest News
AMKAY Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Amkay Products Ltd (AMKAY)?
As of 30 Jan 2026, 01:40 pm IST, Amkay Products Ltd (AMKAY) is currently trading at ₹68.47. The stock has a market capitalization of ₹39.82 (Cr).
Is AMKAY share price Overvalued or Undervalued?
AMKAY is currently trading at a P/E ratio of 11.44x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Amkay Products Ltd share price?
Key factors influencing AMKAY's price include its quarterly earnings growth (Sales Growth: 28.98%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amkay Products Ltd a good stock for long-term investment?
Amkay Products Ltd shows a 5-year Profit Growth of 39.33% and an ROE of 14.79%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.07 before investing.
How does Amkay Products Ltd compare with its industry peers?
Amkay Products Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare AMKAY's P/E of 11.44x and ROE of 14.79% against the industry averages to determine its competitive standing.
What is the P/E ratio of AMKAY and what does it mean?
AMKAY has a P/E ratio of 11.44x compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹11 for every ₹1 of annual earnings.
How is AMKAY performing according to Bull Run's analysis?
AMKAY has a Bull Run fundamental score of 55.9/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does AMKAY belong to?
AMKAY operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amkay Products Ltd.
What is Return on Equity (ROE) and why is it important for AMKAY?
AMKAY has an ROE of 14.79%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Amkay Products Ltd generates profits from shareholders' equity.
How is AMKAY's debt-to-equity ratio and what does it indicate?
AMKAY has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is AMKAY's dividend yield and is it a good dividend stock?
AMKAY offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has AMKAY grown over the past 5 years?
AMKAY has achieved 5-year growth rates of: Sales Growth 7.77%, Profit Growth 39.33%, and EPS Growth -55.84%.
What is the promoter holding in AMKAY and why does it matter?
Promoters hold 73.44% of AMKAY shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is AMKAY's market capitalization category?
AMKAY has a market capitalization of ₹40 crores, placing it in the Small-cap category.
How volatile is AMKAY stock?
AMKAY has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for AMKAY?
AMKAY has a 52-week high of ₹N/A and low of ₹N/A.
What is AMKAY's operating profit margin trend?
AMKAY has a 5-year average Operating Profit Margin (OPM) of 10.07%, indicating the company's operational efficiency.
How is AMKAY's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 28.98% and YoY Profit Growth of 7.65%.
What is the institutional holding pattern in AMKAY?
AMKAY has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.